This study, focusing on EZH2, an important epigenetic regulator, and associated intracellular signaling molecules, demonstrates that both EZH2 and pERK expression are upregulated in ATLL, contributing to tumor aggressiveness in biopsied patients’ tumor tissues. Here, EZH2 is linked to neoplasm.